Average Co-Inventor Count = 4.80
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Santaris Pharma A/s (11 from 44 patents)
2. Enzon Pharmaceuticals, Inc. (8 from 52 patents)
3. Roche Innovation Center Copenhagen A/s (7 from 46 patents)
4. Santaris Pharama A/s (1 from 1 patent)
19 patents:
1. 9994850 - Antisense design
2. 9951333 - Antisense design
3. 9938527 - Potent LNA oligonucleotides for the inhibition of HIF-1A expression
4. 9890383 - Antisense design
5. 9708614 - Antisense design
6. 9447138 - Potent LNA oligonucleotides for the inhibition of HIF-1a expression
7. 9428534 - Antisense design
8. 9045518 - Amino-LNA, thio-LNA and alpha-L-oxy-LN
9. 8785617 - Oligomeric compounds for the modulation of HIF-1A expression
10. 8410071 - Potent LNA oligonucleotides for the inhibition of HIF-1A expression
11. 8357670 - Oligomeric compounds for the modulation of HIF-1A expression
12. 8207140 - Oligomeric compounds for the modulation of HIF-1α expression
13. 8026355 - Oligomeric compounds for the modulation of survivin expression
14. 7939507 - Potent LNA oligonucleotides for the inhibition of HIF-1a expression
15. 7846911 - Oligomeric compounds for the modulation of HIF-1alpha expression